Is Esperion Therapeutics Inc (ESPR) a Leader in the Healthcare Sector?

Esperion Therapeutics Inc (ESPR) is around the top of the Healthcare sector according to InvestorsObserver. ESPR received an overall rating of 33, which means that it scores higher than 33% of stocks. Additionally, Esperion Therapeutics Inc scored a 87 in the Healthcare sector, ranking it higher than 87% of stocks in that sector.

ESPR has an Overall Score of 33. Find out what this means to you and get the rest of the rankings on ESPR!

See Full ESPR Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 33 would rank higher than 33 percent of all stocks. Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Esperion Therapeutics Inc Stock Today?

Esperion Therapeutics Inc (ESPR) stock is trading at $2.61 as of 12:58 PM on Wednesday, Feb 7, a gain of $0.03, or 1.16% from the previous closing price of $2.58. The stock has traded between $2.54 and $2.74 so far today. Volume today is light. So far 2,957,290 shares have traded compared to average volume of 7,293,948 shares. Click Here to get the full Stock Report for Esperion Therapeutics Inc stock.